Selective Nonsteroidal Glucocorticoid Receptor Modulators for the Inhaled Treatment of Pulmonary Diseases.

Autor: Hemmerling M; Respiratory, Inflammation & Autoimmunity, Innovative Medicines and Early Development Biotech Unit, AstraZeneca , Pepparedsleden 1, Mölndal, SE 43183, Sweden., Nilsson S; AstraZeneca R&D Lund , Scheelevägen 1, Lund, SE 22187, Sweden., Edman K; Discovery Sciences, Innovative Medicines and Early Development Biotech Unit, AstraZeneca , Pepparedsleden 1, Mölndal, SE 43183, Sweden., Eirefelt S; AstraZeneca R&D Lund , Scheelevägen 1, Lund, SE 22187, Sweden., Russell W; AstraZeneca R&D Lund , Scheelevägen 1, Lund, SE 22187, Sweden., Hendrickx R; Respiratory, Inflammation & Autoimmunity, Innovative Medicines and Early Development Biotech Unit, AstraZeneca , Pepparedsleden 1, Mölndal, SE 43183, Sweden., Johnsson E; Respiratory, Inflammation & Autoimmunity, Innovative Medicines and Early Development Biotech Unit, AstraZeneca , Pepparedsleden 1, Mölndal, SE 43183, Sweden., Kärrman Mårdh C; Respiratory, Inflammation & Autoimmunity, Innovative Medicines and Early Development Biotech Unit, AstraZeneca , Pepparedsleden 1, Mölndal, SE 43183, Sweden., Berger M; Medicinal Chemistry Berlin, Drug Discovery, Pharmaceuticals, Bayer AG , Berlin 13353, Germany., Rehwinkel H; Medicinal Chemistry Berlin, Drug Discovery, Pharmaceuticals, Bayer AG , Berlin 13353, Germany., Abrahamsson A; Respiratory, Inflammation & Autoimmunity, Innovative Medicines and Early Development Biotech Unit, AstraZeneca , Pepparedsleden 1, Mölndal, SE 43183, Sweden., Dahmén J; AstraZeneca R&D Lund , Scheelevägen 1, Lund, SE 22187, Sweden., Eriksson AR; Respiratory, Inflammation & Autoimmunity, Innovative Medicines and Early Development Biotech Unit, AstraZeneca , Pepparedsleden 1, Mölndal, SE 43183, Sweden., Gabos B; AstraZeneca R&D Lund , Scheelevägen 1, Lund, SE 22187, Sweden., Henriksson K; AstraZeneca R&D Lund , Scheelevägen 1, Lund, SE 22187, Sweden., Hossain N; AstraZeneca R&D Lund , Scheelevägen 1, Lund, SE 22187, Sweden., Ivanova S; AstraZeneca R&D Lund , Scheelevägen 1, Lund, SE 22187, Sweden., Jansson AH; AstraZeneca R&D Lund , Scheelevägen 1, Lund, SE 22187, Sweden., Jensen TJ; Respiratory, Inflammation & Autoimmunity, Innovative Medicines and Early Development Biotech Unit, AstraZeneca , Pepparedsleden 1, Mölndal, SE 43183, Sweden., Jerre A; AstraZeneca R&D Lund , Scheelevägen 1, Lund, SE 22187, Sweden., Johansson H; AstraZeneca R&D Lund , Scheelevägen 1, Lund, SE 22187, Sweden., Klingstedt T; AstraZeneca R&D Lund , Scheelevägen 1, Lund, SE 22187, Sweden., Lepistö M; Respiratory, Inflammation & Autoimmunity, Innovative Medicines and Early Development Biotech Unit, AstraZeneca , Pepparedsleden 1, Mölndal, SE 43183, Sweden., Lindsjö M; Pharmaceutical Sciences, Innovative Medicines and Early Development Biotech Unit, AstraZeneca , Pepparedsleden 1, Mölndal, SE 43183, Sweden., Mile I; AstraZeneca R&D Lund , Scheelevägen 1, Lund, SE 22187, Sweden., Nikitidis G; AstraZeneca R&D Lund , Scheelevägen 1, Lund, SE 22187, Sweden., Steele J; Respiratory, Inflammation & Autoimmunity, Innovative Medicines and Early Development Biotech Unit, AstraZeneca , Pepparedsleden 1, Mölndal, SE 43183, Sweden., Tehler U; Pharmaceutical Sciences, Innovative Medicines and Early Development Biotech Unit, AstraZeneca , Pepparedsleden 1, Mölndal, SE 43183, Sweden., Wissler L; Discovery Sciences, Innovative Medicines and Early Development Biotech Unit, AstraZeneca , Pepparedsleden 1, Mölndal, SE 43183, Sweden., Hansson T; Respiratory, Inflammation & Autoimmunity, Innovative Medicines and Early Development Biotech Unit, AstraZeneca , Pepparedsleden 1, Mölndal, SE 43183, Sweden.

Publikováno v: Journal of medicinal chemistry [J Med Chem] 2017 Oct 26; Vol. 60 (20), pp. 8591-8605. Date of Electronic Publication: 2017 Oct 12.

Growth of lactic acid bacteria and Rhizopus oligosporus during barley tempeh fermentation.

Autor: Feng XM; Department of Microbiology, Swedish University of Agricultural Sciences (SLU), P.O. Box 7025, SE-750 07, Sweden. xinmei.feng@mikrob.slu.se, Eriksson AR, Schnürer J

Publikováno v: International journal of food microbiology [Int J Food Microbiol] 2005 Oct 25; Vol. 104 (3), pp. 249-56. Date of Electronic Publication: 2005 Jun 24.

A two-component regulatory system, pehR-pehS, controls endopolygalacturonase production and virulence in the plant pathogen Erwinia carotovora subsp. carotovora.

Autor: Flego D; Department of Plant Biology, Uppsala Genetic Center, Swedish University of Agricultural Sciences., Marits R, Eriksson AR, Kõiv V, Karlsson MB, Heikinheimo R, Palva ET

Publikováno v: Molecular plant-microbe interactions : MPMI [Mol Plant Microbe Interact] 2000 Apr; Vol. 13 (4), pp. 447-55.

Histologic investigations on 33 retrieved Nobelpharma implants.

Autor: Albrektsson T; Department of Handicap Research, University of Gothenburg, Sweden., Eriksson AR, Friberg B, Lekholm U, Lindahl L, Nevins M, Oikarinen V, Roos J, Sennerby L, Astrand P

Publikováno v: Clinical materials [Clin Mater] 1993; Vol. 12 (1), pp. 1-9.

The long-term efficacy of currently used dental implants: a review and proposed criteria of success.

Autor: Albrektsson T, Zarb G, Worthington P, Eriksson AR

Publikováno v: The International journal of oral & maxillofacial implants [Int J Oral Maxillofac Implants] 1986 Summer; Vol. 1 (1), pp. 11-25.